The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anaemic patients with chronic kidney disease not on renal replacement therapy.

Official Title

Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease.

Conditions

  • Chronic Kidney Failure

Study Type

Interventional

Study Design

Treatment, Randomised, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study.

Further Details

Study Start

March 2004

Eligibility & Criteria

  • Ages Eligible for Study: 18 years and older
  • Genders Eligible for Study:

     

     Both

Inclusion Criteria:

  • Chronic kidney disease
  • Anaemia (Hb 8 – 11.5 g/dl)
  • Age above 18 years
  • Signed informed consent

Exclusion Criteria:

  • Rapid progression of kidney disease
  • Need for dialysis
  • Uncontrolled hypertension

Total Enrolment

50

Contact Details

 

Roland M Schaefer, MD

 

University Hospital Muenster

Location:

Westphalia University Hospital Muenster 
Muenster, Westphalia,
Germany, 48149